Business
- Pfizer and BioNTech’s Combo Shot Missed the Mark. Is It Time to Sell?
19 Aug, 2024 - Bavarian Nordic can provide another 10 million extra mpox vaccination doses by end of 2025
19 Aug, 2024 - Nearly one-third of Covid-19 vaccines discarded after expiration: lawmaker
19 Aug, 2024 - Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval
18 Aug, 2024 - Mega vaccine plant in offing
18 Aug, 2024 - Northern Bavarian countries expand smallpox vaccine production amid global health emergency
18 Aug, 2024 - University of Pennsylvania Suing German Drugmaker BioNTech Over COVID-19 Vaccine Payments
17 Aug, 2024 - Mpox Outbreak Sends Stock of Vaccine Maker Bavarian Nordic Soaring
16 Aug, 2024 - Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
16 Aug, 2024 - WHO chief urges increase in cholera vaccine production amid global shortage
16 Aug, 2024 - SK Bioscience sells stake in US vaccine developer Novavax
16 Aug, 2024 - Mpox Gives Denmark Yet Another Way to Show Its Pharma Dominance
16 Aug, 2024 - To counter mpox, vaccine maker could ramp up by another 8 million doses next year
16 Aug, 2024 - Watch Tonix Hopes to Get New Mpox Vaccine to Market
16 Aug, 2024 - Nykode receives patent for cancer vaccine in the US
15 Aug, 2024 - WHO Calls For Cholera Vaccine Production Boost
15 Aug, 2024 - Oral Vaccine Focused Penny Stock Vaxart Is ‘Uniquely Positioned’, Analyst Sees Almost 83% Upside
15 Aug, 2024 - Health stocks are surging after the WHO declared monkeypox a global emergency
15 Aug, 2024 - Mpox Vaccine Maker To Ramp Up Production After WHO Health Emergency
15 Aug, 2024 - MPox Vaccine Manufacturing in Africa ‘Unlikely’; Donations Are Most Likely Supply Channel, says Bavarian Nordic Official
15 Aug, 2024 - Danish monkeypox-vaccine maker surges 17% after global health emergency declared
15 Aug, 2024 - Health stocks jump as WHO declares mpox global health emergency
15 Aug, 2024 - Bavarian Nordic says it can supply 10M mpox jabs by end of 2025
15 Aug, 2024 - Global DNA Vaccination Market Size & Share Analysis – By Product
15 Aug, 2024 - TD Vaccine Market Set to Expand from $5.5 Billion in 2023 to $7.84
15 Aug, 2024 - AstraZeneca said to be wavering on £450m UK vaccine plant
15 Aug, 2024 - EXCLUSIVE-Mpox: Vaccine group Gavi says it has up to $500 million for shots
15 Aug, 2024 - Shares in Danish mpox vaccine maker Bavarian Nordic soar 12% as WHO declares a global health emergency
15 Aug, 2024 - Bavarian Nordic receives EU order for 175,420 mpox vaccination doses – donates 40,000 to Africa
14 Aug, 2024 - Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based Vaccines
14 Aug, 2024 - AstraZeneca’s new £450m UK vaccine hub under threat from Reeves’ state aid review
14 Aug, 2024 - Bavarian Says It Can Meet Mpox Shot Demand, Shares Jump
14 Aug, 2024 - Blow to AstraZeneca vaccine project as Reeves plans funding cuts
14 Aug, 2024 - Pharmalittle: We’re reading about an AstraZeneca U.K. vaccine plant, Medicare premiums, and more
14 Aug, 2024 - Ghana minister of health in SA on mission to hunt for vaccine manufacturing operations
13 Aug, 2024 - Q2 Recap: Smooth Sailing for Some, but COVID Cliff and Vaccine Issues Thwart Others
13 Aug, 2024 - Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
13 Aug, 2024 - Bavarian Nordic to donate mpox vaccine doses following African emergency declaration
13 Aug, 2024 - Pfizer Faces Challenges After COVID-19 Vaccine Boom
12 Aug, 2024
0 Comments